MENU
+Compare
IFRX
Stock ticker: NASDAQ
AS OF
Dec 23, 11:51 AM (EDT)
Price
$2.36
Change
+$0.12 (+5.36%)
Capitalization
132.19M

IFRX InflaRx NV Forecast, Technical & Fundamental Analysis

a developer of biopharmaceutical products

Industry Biotechnology
IFRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for IFRX with price predictions
Dec 20, 2024

IFRX's RSI Indicator peaks and leaves overbought zone

The 10-day RSI Oscillator for IFRX moved out of overbought territory on December 10, 2024. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 24 instances where the indicator moved out of the overbought zone. In of the 24 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on December 12, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on IFRX as a result. In of 101 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for IFRX turned negative on December 12, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IFRX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where IFRX advanced for three days, in of 210 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 102 cases where IFRX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. IFRX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.952) is normal, around the industry mean (14.556). P/E Ratio (0.000) is within average values for comparable stocks, (87.563). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.739). IFRX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (769.231) is also within normal values, averaging (256.215).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IFRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
IFRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

IFRX is expected to report earnings to fall 16.23% to -25 cents per share on March 20

InflaRx NV IFRX Stock Earnings Reports
Q4'24
Est.
$-0.25
Q3'24
Missed
by $0.05
Q2'24
Missed
by $0.04
Q1'24
Beat
by $0.02
Q4'23
Missed
by $0.09
The last earnings report on November 08 showed earnings per share of -30 cents, missing the estimate of -25 cents. With 21.18K shares outstanding, the current market capitalization sits at 132.19M.
A.I. Advisor
published General Information

General Information

a developer of biopharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
Winzerlaer Strasse 2
Phone
+49 3641508180
Employees
66
Web
https://www.inflarx.de
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SMAPX10.190.21
+2.10%
Westwood Salient MLP & Engy Infras A
HWMZX54.020.62
+1.16%
Hotchkis & Wiley Mid Cap Value Z
TRWIX20.840.04
+0.19%
Transamerica International Equity I2
GLXZ2.74N/A
N/A
Galaxy Gaming, Inc.
UOLGY14.95-0.15
-0.99%
UOL Group Ltd.

IFRX and Stocks

Correlation & Price change

A.I.dvisor tells us that IFRX and CRNX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IFRX and CRNX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IFRX
1D Price
Change %
IFRX100%
+5.16%
CRNX - IFRX
32%
Poorly correlated
+1.63%
NNVC - IFRX
30%
Poorly correlated
+2.76%
BLPH - IFRX
29%
Poorly correlated
N/A
XENE - IFRX
28%
Poorly correlated
-0.69%
ALLO - IFRX
28%
Poorly correlated
+1.63%
More